Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Budesonide for Intestinal GVHD
NCT00128739Phase 3Completed
- Sponsor
- Rafa Laboratories
- Start
- Jan 2001
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Graft-versus-host disease of the gastrointestinal tract and graft-versus-host disease (GVHD) comparing Budesonide with Placebo (2 arms). Started Jan 2001; status: completed.
02
Drugs
budesonide
03
Conditions
Graft-versus-host disease of the gastrointestinal tractgraft-versus-host disease (GVHD)
Beyond the preview
Go deeper on NCT00128739.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00128739.